V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320002891 | 320001719 | null | 100 | null | 2014-03-12 | 2014-03-15 | PEMBROLIZUMAB | 02 | N | 320017117 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002892 | 320001719 | null | 84.4 | Neo-adjuvant (N) | 2016-06-12 | 2016-06-13 | Abiraterone | 2 | N | 320017117 | CETUXIMAB |
| 320002893 | 320001720 | 1.65 | 77.1 | Curative (C) | 2014-02-18 | 2014-02-18 | Temozolomide 200mg/m2 | 02 | N | 320017125 | CARBOPLATIN + DOCETAXEL |
| 320002894 | 320001721 | 1.75 | 73.4 | Neo-adjuvant (N) | null | 2013-09-22 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320017137 | TRIAL |
| 320002895 | 320001722 | 1.78 | null | Neo-adjuvant (N) | 2013-08-26 | 2013-09-04 | Mitomycin Intravesical | N | N | 320017139 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002896 | 320001723 | 1.67 | 105 | null | 2017-03-01 | 2017-03-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | Y | N | 320017142 | VINBLASTINE |
| 320002897 | 320001724 | 1.68 | 63.8 | null | 2014-10-07 | 2014-11-01 | TCH (21 day Trastuzumab) Maint | N | N | 320017144 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002898 | 320001725 | 1.56 | 69.5 | Curative (C) | 2013-10-21 | 2013-10-28 | Capecitabine + Oxaliplatin 21day | N | null | 320017154 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320002899 | 320001726 | 1.8 | 96.5 | Palliative (P) | 2014-12-01 | 2014-12-12 | PEMBROLIZUMAB | 02 | N | 320017159 | TCF |
| 320002900 | 320001727 | null | 109.6 | Adjuvant (A) | null | 2014-05-08 | CARBOPLATIN + FLUOROURACIL | null | null | 320017161 | BENDAMUSTINE + RITUXIMAB |
| 320002901 | 320001728 | 1.7 | null | Palliative (P) | 2017-03-02 | 2017-03-02 | Bortezomib + Cyclophos + Dex | N | N | 320017164 | CETUXIMAB + RT |
| 320002902 | 320001729 | 1.6 | 93.9 | Palliative (P) | 2013-07-19 | 2013-08-02 | PACLITAXEL | N | null | 320017165 | CETUXIMAB |
| 320002903 | 320001730 | 1.68 | 69.3 | Palliative (P) | 2016-05-11 | 2016-05-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320017168 | VINFLUNINE |
| 320002904 | 320001731 | 1.75 | 93.3 | Palliative (P) | null | 2014-08-12 | CETUXIMAB | null | null | 320017177 | CARBO + FLUOROURACIL |
| 320002905 | 320004901 | 1.63 | null | Neo-adjuvant (N) | 2015-10-07 | 2015-10-19 | CHOP R | N | N | 320017178 | CETUXIMAB + RT |
| 320002906 | 320001732 | 1.59 | 63 | Palliative (P) | 2015-11-28 | 2017-02-21 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320017180 | CISPLATIN + GEMCITABINE |
| 320002907 | 320001733 | 1.58 | 71.2 | Adjuvant (A) | 2016-06-14 | 2016-07-11 | Bevacizumab 7.5mg/kg | N | Y | 320017185 | VIDE |
| 320002908 | 320004902 | 1.61 | 53 | Neo-adjuvant (N) | null | 2015-11-19 | TCH (21 day Trastuzumab) Maint | null | null | 320017195 | CETUXIMAB |
| 320002909 | 320001734 | 1.72 | 67.3 | Curative (C) | 2015-01-21 | 2015-01-25 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 320017198 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002910 | 320001735 | 1.59 | 73 | Palliative (P) | 2016-11-16 | 2016-11-20 | Folfirinox | N | N | 320017206 | CARBOPLATIN + RT |
| 320002911 | 320001735 | 1.72 | 91 | Neo-adjuvant (N) | 2017-07-28 | 2017-08-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320017206 | CARBOPLATIN + RT |
| 320002912 | 320001736 | 1.72 | 87 | Palliative (P) | 2015-06-18 | 2015-07-09 | Fluorouricil + Folonic Acid (MdG) | 02 | Y | 320017210 | DOCETAXEL |
| 320002913 | 320001737 | 1.69 | 118.8 | Adjuvant (A) | 2015-03-19 | 2015-03-20 | PEMBROLIZUMAB | 02 | N | 320017212 | CARBOPLATIN + RT |
| 320002914 | 320001738 | 1.84 | 89 | Palliative (P) | 2016-05-26 | 2016-06-05 | Atezolizumab | N | N | 320017217 | CAPECITABINE + CARBOPLATIN |
| 320002915 | 320001739 | 1.71 | null | Adjuvant (A) | 2015-10-15 | 2015-10-23 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 320017230 | CETUXIMAB + RT |
| 320002916 | 320001740 | 1.64 | 62.1 | Adjuvant (A) | 2017-08-01 | 2017-08-01 | Oxaliplatin + Modified de Gramont | N | N | 320017233 | CISPLATIN + ETOPOSIDE |
| 320002917 | 320001741 | 1.79 | 0 | Adjuvant (A) | 2015-03-28 | 2015-04-07 | CARBO + GEFITINIB + PEMETREXED | 02 | N | 320017236 | IRINOTECAN + MDG |
| 320002918 | 320001741 | 1.55 | 57.6 | Palliative (P) | 2017-10-26 | 2017-12-24 | CISPLATIN + GEMCITABINE | N | N | 320017236 | TEMOZOLOMIDE |
| 320002919 | 320001742 | 1.71 | 56.2 | Palliative (P) | 2017-09-15 | 2017-09-17 | CNS Low Grade Glioma Vinblastine | 02 | N | 320017245 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002920 | 320001742 | 1.66 | null | Adjuvant (A) | 2015-03-07 | 2015-03-08 | Carbo F | 02 | null | 320017245 | OXALIPLATIN + MDG |
| 320002921 | 320001742 | 1.57 | 51 | Neo-adjuvant (N) | 2014-11-09 | 2014-11-20 | THALIDOMIDE | 02 | N | 320017245 | CARBOPLATIN + ETOPOSIDE |
| 320002922 | 320001742 | null | 71 | Disease modification (D) | 2016-06-16 | 2016-06-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320017245 | CETUXIMAB + RT |
| 320002923 | 320001743 | 1.57 | 71.2 | Palliative (P) | 2013-12-10 | 2013-12-17 | ICON8B TRIAL | N | N | 320017263 | TEMOZOLOMIDE + RT |
| 320002925 | 320001745 | 1.76 | 82 | Adjuvant (A) | 2015-04-02 | 2015-04-24 | CARBOPLATIN + RT | N | N | 320017271 | CETUXIMAB + RT |
| 320002926 | 320001745 | 1.85 | 95.4 | Adjuvant (A) | 2017-07-31 | 2017-08-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017271 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 320002927 | 320001746 | 1.62 | 68.9 | Curative (C) | 2014-03-21 | 2014-03-22 | Enzalutamide | 02 | N | 320017273 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002928 | 320001747 | 1.7 | 87.5 | Neo-adjuvant (N) | 2016-05-28 | 2016-09-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320017276 | ATEZOLIZUMAB |
| 320002929 | 320004907 | 1.59 | 79.4 | Palliative (P) | 2018-05-07 | 2018-05-07 | Carboplatin + Etoposide iv&po | 2 | N | 320017277 | CARBOPLATIN + ETOPOSIDE |
| 320002930 | 320001748 | 1.72 | 79.9 | Curative (C) | 2014-12-22 | 2014-12-22 | FLUOROURACIL + MITOMYCIN + RT | N | Y | 320017283 | CARBOPLATIN + VINORELBINE |
| 320002931 | 320001748 | 1.81 | 64.8 | Adjuvant (A) | 2017-02-21 | 2017-02-26 | ECX | N | N | 320017283 | CISPLATIN + GEMCITABINE |
| 320002933 | 320001749 | 1.79 | 71.7 | Curative (C) | 2017-05-16 | 2017-05-23 | Cisplatin + Etoposide (3 day) | N | N | 320017293 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002934 | 320001750 | 1.69 | 76.8 | Adjuvant (A) | 2014-07-06 | 2014-07-22 | CETUXIMAB | N | Y | 320017299 | TEMOZOLOMIDE + RT |
| 320002936 | 320001752 | 1.7 | 66 | Palliative (P) | 2014-02-27 | 2015-03-02 | CARBOPLATIN + RT | N | N | 320017304 | CISPLATIN + FLUOROURACIL + RT |
| 320002937 | 320001753 | 1.42 | 63 | Disease modification (D) | 2014-02-28 | 2014-03-26 | Carboplatin + Etoposide iv&po | N | N | 320017315 | PAZOPANIB |
| 320002938 | 320001753 | 1.6 | null | Palliative (P) | 2016-10-12 | 2016-10-12 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | N | 320017315 | ICON TRIAL |
| 320002939 | 320001753 | 1.68 | 99 | Curative (C) | 2014-05-25 | 2014-06-11 | CETUXIMAB + RT | N | N | 320017315 | CISPLATIN + GEMCITABINE |
| 320002940 | 320001754 | 1.6 | 93.3 | Curative (C) | 2013-04-07 | 2013-04-21 | Ipilimumab | 02 | Y | 320017346 | CARBOPLATIN + RT |
| 320002941 | 320004910 | 1.68 | 67 | Curative (C) | 2016-07-15 | 2016-07-23 | Oxaliplatin + Modified de Gramont | N | N | 320017348 | CETUXIMAB + RT |
| 320002942 | 320001755 | null | 98.799 | Adjuvant (A) | 2017-06-19 | 2017-06-20 | null | N | null | 320017349 | CARBOPLATIN + PEMETREXED |
| 320002943 | 320001756 | null | 82 | Palliative (P) | 2013-05-18 | 2013-05-18 | GEMCITABINE | N | N | 320017351 | TRIAL |